Skip to content

Clinical trials

Completed Phase 1 Choroidal Neovascularization trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Choroidal Neovascularization Phase: Phase 1 Status: Completed Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20053
20062
20074
20081
20103
20121
20131
20171
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)5
GlaxoSmithKline3
Johns Hopkins University2
Alcon Research1
Clement K. Chan1
Graybug Vision1
Hawaii Pacific Health1
Novartis Pharmaceuticals1
Ophthalmic Consultants of Boston1
Quark Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Choroidal Neovascularization21
Macular Degeneration14
Diabetic Retinopathy2
Geographic Atrophy2
Inflammation2
Macular Edema2
Retinal Vein Occlusion2
Angioid Streaks1
Eye Diseases1
Myopia, Degenerative1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.